Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) showing promising early weight-loss and metabolic data in Phase 2 trials, but it is not yet approved in the UK and carries notable side effects and safety uncertainties
If you have a personal or family history of certain conditions, such as pancreatitis or medullary thyroid carcinoma, or are pregnant or breastfeeding, this treatment approach is not recommended for you
Track your symptoms with Shotsy Keeping a record of when diarrhea occurs can help you and your provider identify patterns
Having the math sorted before starting the taper prevents logistical complications that might otherwise derail the gradual reduction plan
Magnesium glycinate, bound to the amino acid glycine, is absorbed well and tends to be gentle on digestion, which is why it is the common choice when the goal is sleep, calm, and steady regularity rather than a strong flush
Access Wegovy (semaglutide) with your insurance, or pay cash and get it delivered directly to you
